References in periodicals archive ?
List of False Positives and False Negatives on CT CT Diagnosis Histopathological Diagnosis Metastasis Grade III Astrocytoma Meningioma Oligoastrocytoma Cerebral abscess Grade III Astrocytoma GBM Tuberculosis Choroid plexus carcinoma Craniopharyngioma Choroid plexus carcinoma Glioblastoma multiforme Acute infarct Grade II glioma Table 7.
Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
Fiona Doetsch at the Biozentrum of the University of Basel has now shown that the choroid plexus is a key component of the stem cell niche, whose properties change throughout life and affect stem cell behavior.
We classified the present case as congenital hydrocephalus based on the bird's age, history, the course of the clinical signs, and histopathologic observations, even though no obstructions or choroid plexus alterations were detected.
Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: Long-term results of a prospective intent-to-treat study in 115 East African infants.
Approximately two-thirds of the total CSF volume is generated by the choroid plexus, with the remainder produced by extra-choroidal tissue.
A choroid plexus papilloma is usually midline without temporal bone destruction.
American Institute of Ultrasound in Medicine: Basic elements of a standard second-trimester fetal anatomy scan * Focus Structures Head, face, neck Cerebellum Choroid plexus Cisterna magna Lateral cerebral ventricles Midline falx Cavum septi pellucidi Upper lip Nuchal fold** Chest 4-chamber view Outflow tracts, if feasible Abdomen Stomach: presence, size, and situs Kidneys Bladder Umbilical cord insertion site (into fetal abdomen) Umbilical cord vessel number Spine Cervical, thoracic, lumbar, and sacral Extremities Legs and arms: presence or absence Sex * A more detailed fetal anatomic examination may be indicated if an abnormality is found on the standard examination.
Using breakthrough proprietary microencapsulation technology, IMMUPEL(TM), which enables implantation of cell-based therapeutics without immunosuppression, LCT is developing NTCELL, a choroid plexus cell product which is currently in preclinical development to treat neurodegenerative diseases such as Parkinson's disease, Huntington's disease, stroke, and hearing loss.
The most common histologies by age are as follows: in the less than 1 year old age group, tumors arising in the choroid plexus (33%) were more frequent.
It often remains attached to the choroid plexus and can vary in size from 0.